LifeSci Partnering focuses on securing non-dilutive capital and assets for clients
through buy-side and sell-side strategic partnering transactions.
Deal Types & Track Record
- Out-licensing
- In-licensing
- R&D Collaborations
- Product Acquisitions & Divestitures
- Mergers & Acquisitions
0
transactions
0 Billion USD+
deal value
0+
contacts worldwide
Robust Business Development Support
Robust Business
Development Support
Transaction Advisory
- Enhance existing BD capabilities
- Expand existing target list (if needed)
- Initiate a formal partnering process to generate deal tension and maximize value
- Structure deal based on substantial LifeSci transaction experience (e.g., value share split, upfront/milestone/royalty allocations)
- Support deal negotiations, particularly financial terms
Select Highlighted Deals
2021
Exclusive China License
Deal Terms Undisclosed
2021
Various Collaborations
Deal Terms Undisclosed
2019
Global Exclusive Option to License
Undisclosed ($3 Million Upfront)
2019
Ex-US & Japan Exclusive License
$568 Million
2019
Global Exclusive Option to License
$481 Million
2018
Structured Buy-Out
